Neoadjuvant QL1706 plus chemotherapy in patients with stage II–IIIB squamous non-small cell lung cancer: study protocol for a prospective, single-arm, multicentre phase II trial
Abstract Introduction Lung squamous cell carcinoma is a subtype of non-small cell lung cancer (NSCLC) and its biological characteristics or treatment responses might differ from non-squamous NSCLC. Although neoadjuvant immunotherapy combined with chemotherapy has become the guideline-recommended treatment for resectabl...